Literature DB >> 5030808

Importance of dose schedules in adjuvant chemotherapy.

K Karrar.   

Abstract

Mesh:

Substances:

Year:  1972        PMID: 5030808

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN: 0069-0112


× No keyword cloud information.
  8 in total

1.  Postoperative long term chemotherapy for advanced gastric cancer.

Authors:  N Kaibara; K Soejima; T Nakamura; K Inokuchi
Journal:  Jpn J Surg       Date:  1976-06

Review 2.  Progress report. Cytotoxic therapy for gastrointestinal carcinoma.

Authors:  T J Prostman
Journal:  Gut       Date:  1976-04       Impact factor: 23.059

3.  Protracted oral chemotherapy with fluorinated pyrimidines as an adjuvant to surgical treatment for stomach cancer.

Authors:  S Fujimoto; T Akao; B Itoh; I Koshizuka; K Koyano
Journal:  Ann Surg       Date:  1977-04       Impact factor: 12.969

4.  Late results of postoperative long-term cancer chemotherapy for the gastric cancer patients subjected to curative resection.

Authors:  T Kano; R Kumashiro; H Masuda; R Tamada; K Inokuchi
Journal:  Jpn J Surg       Date:  1983-03

5.  Late results of postoperative long term cancer chemotherapy for advanced carcinoma of the stomach.

Authors:  T Kano; R Kumashiro; R Tamada; Y Kodama; K Inokuchi
Journal:  Jpn J Surg       Date:  1981

6.  Postmastectomy morbidity after combination preoperative irradiation and chemotherapy for locally advanced breast cancer.

Authors:  E R Sauter; B L Eisenberg; J P Hoffman; F D Ottery; M C Boraas; L J Goldstein; L J Solin
Journal:  World J Surg       Date:  1993 Mar-Apr       Impact factor: 3.352

7.  5-year follow-up of cytotoxic chemotherapy as an adjuvant to surgery in carcinoma of the bronchus.

Authors:  H Stott; R J Stephens; W Fox; D C Roy
Journal:  Br J Cancer       Date:  1976-08       Impact factor: 7.640

8.  Fifteen-year follow-up of all patients in a study of post-operative chemotherapy for bronchial carcinoma.

Authors:  D J Girling; H Stott; R J Stephens; W Fox
Journal:  Br J Cancer       Date:  1985-12       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.